OR WAIT 15 SECS
Global Pharmacopoeia Solutions LLC
J. Mark Wiggins is owner and compendial consultant with Global Pharmacopoeia Solutions LLC.
September 02, 2020
Processes, people, and tools are needed to comply with the pharmacopoeia and approved drug product registrations.
March 15, 2020
This article details the more operational aspects of monograph submissions, answering the question of how to participate.
The authors present a case study with raw materials and excipients, where a consistent, cross-functional approach is needed to ensure the appropriate selection, sourcing, testing, and filing of the materials used to manufacture bio/pharmaceutical products in a global environment, ensuring compliance with applicable compendial and regulatory requirements.
This article explores another proactive advocacy approach that a bio/pharmaceutical company may take through participation in the development of new and revised monographs in the various pharmacopoeias.